Sloan-Kettering has an estimated 9 percent to 15 percent of New York’s market share for cancer patients, beating out competition from NewYork-Presbyterian Hospital and Mount Sinai Hospital in New York. In 2009, Sloan-Kettering received roughly $4.1 million in gross revenue per hospital bed compared with NewYork-Presbyterian’s $1.4 million and Mount Sinai’s nearly $1.1 million.
Sloan-Kettering has also expanded into the suburbs. It recently received approval to build a cancer center in Harrison, N.Y., despite opposition from local hospitals. Paul Savage, president of consulting firm HealthCare Intelligence, said in the report that Sloan-Kettering picks locations with a good payor mix. A Standard & Poor’s report showed Sloan-Kettering had roughly 5.4 percent of Medicaid patient discharges compared with 14 percent to 16 percent at other hospitals in the region. A spokeswoman for Sloan-Kettering said this data does not accurately reflect the center’s service to the poor because most Medicaid patients in New York state are younger than 65, whereas the median age of patients diagnosed with cancer is 66.
Competitors claim Sloan-Kettering’s name recognition causes cancer patients, particularly those with private insurance, to overlook community hospitals for the well-recognized Sloan-Kettering although they offer similar levels of care, according to the report.
Related Articles on Hospital Oncology:
Cancer Treatment Centers of America Proposal Sparks Opposition in New Hampshire
Adena Medical Center in Ohio Rolls Out New $21M Cancer Center
Cone Health in North Carolina Unveils $15M Cancer Center Expansion, Renovation
